AlphaGen
Access AlphaGen
Company Narratives

Ecopack FY2026: Lower PET Prices Cut Sales, but Margins Widen as Expansion Lifts Debt

Ecopack’s FY2026 sales fell with lower PET-linked pricing, but margins and profit improved. Heavy expansion capex strengthened capacity while raising debt and cash-flow pressure.

Sep 16, 2026

Company Name: Ecopack Limited

Ticker: ECOP

Reporting period: Year ended June 30, 2026 (FY2026). Q4 figures in this article are derived by subtracting the official nine-month FY2026 figures from the official full-year result; they were not separately reported by the company.

Reporting basis: Standalone company financial results. The Board approved the FY2026 result on September 12, 2026 and PSX published it on September 14. The filing contains the full year-end profit or loss, financial position, changes in equity and cash-flow statements. Ecopack’s FY2026 audited annual report was not yet listed on the company’s financial-reports page at the time of this analysis. The nine-month March 2026 statements used to derive Q4 were explicitly unaudited. Official FY2026 result. Company financial-reports page.

Verdict

Ecopack’s FY2026 is a strong example of why revenue growth alone can mislead. Net sales declined 9.3%, yet gross profit rose 11.8%, operating profit increased 10.9% and profit after tax advanced 22.1%. The economic explanation is mostly favorable: management said lower PET resin prices reduced invoice values because selling prices are linked to resin prices, while cost control and operating efficiencies improved conversion of sales into profit. The year-end result confirms that cost of sales fell faster than revenue, widening gross margin to 20.65% from 16.75%. But the improvement came alongside an aggressive investment cycle. Property, plant and equipment rose almost 49%, annual capex exceeded Rs1.1 billion, and financing balances expanded sharply. The next result cycle therefore has two tests: whether the higher-margin operating profile persists, and whether the new capacity begins generating enough cash to justify the debt and capital deployed. Official FY2026 result. Official nine-month management commentary.

AlphaGen model readings

Alpha QoQ Score: 83.83

TTM Performance Score: 83.13

3Y Business Perf Score: 95.70

Sector Leadership Score: 51.33

These four readings are AlphaGen model outputs, not company-reported financial figures. They are presented separately from Ecopack’s public accounts and should not be read as investment advice.

Results at a glance

  • FY2026 net revenue fell 9.3% to Rs6.514 billion from Rs7.183 billion, but cost of sales fell faster—13.6%—to Rs5.169 billion. Official FY2026 result.
  • Gross profit rose 11.8% to Rs1.345 billion. Gross margin expanded to 20.65% from 16.75%, a gain of about 390 basis points. Official FY2026 result.
  • Operating profit increased 10.9% to Rs845.2 million and operating margin improved to 12.97% from 10.61%. Finance cost declined 22.0% to Rs148.0 million. Official FY2026 result.
  • Profit before tax rose 21.8% to Rs697.2 million; profit after tax increased 22.1% to Rs414.9 million; EPS rose to Rs8.60 from Rs7.04. Official FY2026 result.
  • Derived Q4 net revenue fell 17.6% year on year to about Rs1.776 billion, but derived Q4 gross profit rose 16.7% and PAT rose 34.4%. Gross margin for the derived quarter expanded to about 26.88% from 18.98%. Official FY2026 result. Official nine-month filing.
  • Net operating cash flow was Rs704.2 million versus Rs773.5 million, while purchases of property, plant and equipment surged to Rs1.116 billion from Rs366.2 million. Official FY2026 cash-flow statement.
  • The Board recommended a 30% final cash dividend for FY2026; no bonus or right issue was recommended. Official Board announcement.

What improved

The biggest improvement was margin quality. FY2026 revenue declined by Rs668.7 million, but cost of sales fell by roughly Rs810.5 million. That favorable spread added about Rs141.8 million to gross profit despite the smaller top line. Selling and distribution expense rose 9.0% and administrative expense increased 22.2%, so some of the gross-profit benefit was absorbed below the gross line, but operating profit still grew by Rs83.3 million. The business therefore earned more operating profit from a smaller revenue base. Official FY2026 result.

Management’s nine-month explanation is important because it clarifies why falling sales did not mean collapsing demand. Ecopack said net sales for the first nine months were down about 6% mainly because PET resin prices had fallen about 9%; the company’s selling prices move with the prevailing resin price. It also said bottle volumes were hurt by widespread floods in the first quarter. In other words, part of the revenue decline was a price-pass-through effect, not simply a loss of physical volume. Management attributed the improvement in gross and operating margins to operational efficiencies and cost control. Official nine-month directors’ report.

The wider industry backdrop was also supportive but not uniformly strong. Pakistan Bureau of Statistics reported that beverages output rose 3.09% in July–June FY2026, while overall large-scale manufacturing grew 4.98%. However, beverage output in June alone was down 16.33% year on year. That mixed pattern is consistent with an end market that recovered over the year but remained volatile late in the period; it should not be treated as a direct measure of Ecopack’s own volumes. PBS June 2026 manufacturing data.

Q4: lower sales, much stronger unit economics

The derived June quarter shows the FY2026 story most clearly. Subtracting the official nine-month figures from the full-year result gives Q4 net revenue of approximately Rs1.776 billion, down 17.6% from about Rs2.156 billion in the comparable quarter. Yet derived cost of sales fell 25.7% to roughly Rs1.299 billion. Gross profit therefore rose 16.7% to about Rs477.4 million, taking gross margin to 26.88% from 18.98%. Derived operating profit increased 16.3% to Rs311.9 million, with operating margin rising to 17.56% from 12.44%. Official FY2026 result. Official nine-month result.

That Q4 margin expansion is analytically more important than the revenue decline. Management did not publish a separate Q4 explanation, so the precise quarter-specific cause should not be overstated. The most reasonable inference is that the same factors visible through March—lower PET-linked input/selling prices, cost discipline and manufacturing efficiency—continued to improve conversion economics. The inference is supported by the arithmetic, but it is not a new Q4 management statement.

Derived Q4 profit before tax was approximately Rs266.2 million, up 15.8%, while PAT rose 34.4% to about Rs173.9 million. The faster PAT growth partly reflects a lower quarterly tax charge: derived Q4 tax expense was about Rs92.3 million versus Rs100.5 million. Finance cost, meanwhile, rose about 19.5% in the derived quarter to Rs45.6 million, so the full-year decline in finance cost was largely earned earlier in the year rather than in Q4. Official FY2026 result. Official nine-month filing.

Finance cost: a recurring benefit, but not guaranteed

For the nine months through March, management explicitly linked the 32% reduction in finance cost to lower KIBOR and the SBP policy-rate environment, along with improved bank spreads and more efficient use of credit lines. It said average KIBOR fell to 10.96% from 14.31%. The wider monetary backdrop supports that explanation: SBP cut the policy rate from 11.0% to 10.5% effective December 16, 2025. Full-year finance cost ultimately fell 22% to Rs148.0 million even though year-end financing balances were much higher. Ecopack management commentary. SBP policy-rate notification.

The distinction matters for the next cycle. Lower benchmark rates can remain supportive, but the company ended FY2026 with substantially more debt because of its investment program. A larger borrowing base can offset some of the benefit of lower interest rates. Q4’s rise in derived finance cost is an early reminder that financing expense should be monitored against both KIBOR and average debt, not policy rates alone.

The expansion program changed the balance sheet

Ecopack invested heavily during FY2026. Purchases of property, plant and equipment reached Rs1.116 billion, more than three times the prior year’s Rs366.2 million. Year-end property, plant and equipment increased 48.9% to Rs2.793 billion, and total assets rose 36.0% to Rs4.550 billion. This is not a small maintenance-capex year; the balance sheet shows a step-up in productive capacity and infrastructure investment. Official FY2026 financial position and cash flow.

The investment was foreshadowed in the March directors’ report. Management said additional bottle-blowing capacity had already come on stream, that preform manufacturing capacity was being substantially expanded by year-end, and that approximately 2 MW of solar generation was planned to come online within Q4 FY2026. The September result filing does not separately certify the commissioning status of each project, so it is safer to say that the year-end capex and asset build are consistent with the announced expansion program rather than assume every project was fully commissioned. Official nine-month outlook.

Cash conversion weakened despite higher profit

The cash-flow statement is the main counterweight to the stronger income statement. Net cash generated from operating activities declined to Rs704.2 million from Rs773.5 million even though PAT rose 22%. Working capital absorbed Rs177.8 million, compared with a Rs108.9 million release a year earlier. The largest FY2026 uses inside working capital were a Rs189.1 million increase in loans and advances and a Rs79.0 million increase in inventories; lower trade debts and higher payables partly offset those outflows. Official FY2026 cash-flow statement.

After the Rs1.116 billion of property, plant and equipment purchases, operating cash flow was not enough to fund the investment internally. As an analytical subtotal—not a company-reported free-cash-flow measure—operating cash flow less PPE purchases was approximately negative Rs412 million, versus positive roughly Rs407 million in FY2025. Financing cash flow consequently swung to a Rs514.7 million inflow from a Rs391.6 million outflow, including Rs555.6 million of long-term finance proceeds and a net Rs151.5 million increase in short-term borrowings. Official FY2026 cash-flow statement.

The year-end balance sheet shows the same financing trade-off. Long-term secured finance rose to Rs546.6 million from Rs100.7 million; short-term borrowings and running finance increased to Rs798.3 million from Rs636.4 million; and current maturities of non-current liabilities rose to Rs141.6 million from Rs68.9 million. Combined, those financing balances were about 84% higher than a year earlier. Equity also strengthened 19.4% to Rs1.991 billion and cash more than doubled to Rs210.8 million, so this is not simply a liquidity deterioration—but leverage and debt service are now more important variables. Official FY2026 statement of financial position.

Recurring versus exceptional and accounting effects

  • More recurring if sustained: lower resin-linked cost intensity, manufacturing efficiencies, higher gross and operating margins, lower benchmark funding rates, and demand from beverage and liquid-packaging customers.
  • Investment-cycle effect: the jump in capex, property and equipment, and borrowing is not an earnings one-off; it is a structural balance-sheet change that should eventually be judged by utilization, incremental revenue, energy savings and cash returns.
  • Accounting-estimate change: during FY2026, Ecopack changed plant and machinery depreciation from straight-line to reducing balance and revised estimated useful life to 30 years, applied prospectively. The nine-month filing does not quantify the earnings impact. It therefore affects comparability, but there is no basis to assign a specific portion of FY2026 profit growth to the change. Official accounting-policy note.
  • No large exceptional income item is visible in the FY2026 result announcement. Profit growth primarily came through gross-margin expansion and lower finance cost rather than a disclosed non-recurring gain. Official FY2026 result.

What weakened / needs attention

  • Revenue remained lower for the full year, and derived Q4 revenue fell 17.6% year on year. The margin expansion more than protected profit, but a durable growth story eventually requires the new capacity to translate into physical volume and revenue growth.
  • Operating cash flow declined despite higher earnings, while capex accelerated sharply. The gap was financed externally, increasing the importance of cash conversion and debt repayment in FY2027.
  • Current assets rose 19.7%, but current liabilities increased 27.5%, reducing the current ratio to about 1.08 times from 1.15 times. Inventory increased 21.4% to Rs575.3 million, although trade debts fell modestly. Official FY2026 financial position.
  • PET resin remains the key input risk. Management noted that resin is a downstream crude-oil derivative and warned in March that supply-chain disruption, freight and petrochemical price volatility could increase the cost base. This matters more after a year in which lower resin prices supported lower selling prices and improved cost economics. Official nine-month risk discussion.

Dividend and corporate actions

The Board recommended a final cash dividend of 30% for the year ended June 30, 2026, compared with the 20% final dividend paid for FY2025. No bonus shares, right issue or other entitlement was recommended. The FY2026 cash-flow statement records Rs93.3 million of dividends paid during the year, which relates to the prior distribution rather than the newly recommended FY2026 final dividend. Official FY2026 Board result and cash flow.

What to monitor next

  • Volume versus price: separate physical bottle/preform volume growth from PET-resin-linked selling-price movements. FY2026 showed why nominal sales can fall even when profitability improves.
  • Gross margin: derived Q4 margin reached roughly 26.9%, well above the 20.7% full-year level. Whether that margin persists will reveal how much of the improvement is structural efficiency versus input-price timing and mix.
  • Capacity utilization and commissioning: look for explicit disclosure on the enlarged preform capacity, bottle-blowing assets and the planned 2 MW solar project, including utilization and savings after commissioning.
  • Debt and finance cost: the company benefited from lower KIBOR in FY2026, but it now carries a materially larger financing base. The next result should show whether new capacity can generate cash faster than debt service grows.
  • Working capital and cash conversion: loans and advances, inventories, trade payables and operating cash flow need to normalize after the investment build. Profit growth without stronger cash conversion would weaken the quality of the expansion story.
  • End-market demand: PBS reported beverages production up 3.09% for FY2026 but sharply weaker in June. Watch whether beverage-sector growth re-accelerates as the expanded capacity becomes available. PBS manufacturing data.

Bottom line

Ecopack exited FY2026 more profitable but also more capital-intensive. Lower PET-linked pricing reduced the reported top line, yet cost of sales fell faster and margins expanded to their strongest levels in the recent public history. Full-year profit growth was supported by better operating economics and lower finance cost, not by a disclosed exceptional gain. The derived Q4 result strengthens that conclusion because revenue fell sharply while gross and operating profits still increased. Official FY2026 result.

The unresolved question is capital productivity. Ecopack spent more than Rs1.1 billion on property, plant and equipment and ended the year with much higher financing balances. That investment can be constructive if the preform, bottle and energy projects raise utilization, protect margins and produce incremental cash. If demand or resin economics weaken, the larger debt base could instead dilute the benefit of lower interest rates. For the next cycle, the most useful indicators are therefore physical volume, gross margin, utilization, operating cash flow and debt—not revenue growth in isolation.

Sources

Explore more research

All articles